Horizon Discovery

Horizon Discovery is owned by Revvity.

Revvity is one of the...

• Forbes Global 2000 (#1756);
• Fortune 500 (#682);
• Russell 3000;
• S&P 500.

Revvity is a company listed under the stock ticker RVTY (US).

Revvity has a direct presence in 2 countries.

Revvity has 4 subsidiaries including BioLegend, Horizon Discovery and Immunodiagnostic Systems.

They are in:

• Biotechnology40%
• Healthcare20%
• Other40%

View the org chart displaying its 2 main executives

Most searched biographies at Horizon Discovery

• Jesus Zurdo, Global Head Cell, Gene Therapy & Bioproduction
• Kelly Grimsley, Head of Operations

Popular executive movements at Revvity

• Sophie Vandebroek has joined the company as Director  (posted on January 26 2024).
• Michael Klobuchar has joined the company as Director  (posted on January 26 2024).

Create your alert
to follow the executive moves at Horizon Discovery.

Revvity has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).
• Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Horizon Discovery

• MDIC Partners with HD to Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics
• iTreg Suppression Assay Service
• MDIC Partners with PKIHD to Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics
• Medical Device Innovation Consortium Launches Initiative to Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics
• Horizon Discovery offers CHOSOURCE™ platform for COVID-19-related therapeutics and diagnostics
• cDNA & ORF clones
• MGC cDNAs
• Horizon Discovery offers CHOSOURCE™ platform for COVID-19-related therapeutics and diagnostics
• PerkinElmer’s Horizon Discovery CHOSOURCE Platform Expanding To Include CHO-K1 ADCC+ Expression Cell Line for Development of Therapeutic Antibodies in Oncology, Infectious Disease and Autoimmune ConditionsMenu
• Horizon Discovery grants a multi-product use license of its GS knockout CHO K1 cell line to NGM BioMenu
• View more press releases Close

Social media about Horizon Discovery

• Horizon Discovery on Wikipedia, Google News & Yahoo Finance
• Horizon Discovery on LinkedIn, Twitter & YouTube

Contact by email its executives including Jesus Zurdo

Call Horizon Discovery at +44 122...

View the org chart

Register to receive your alert

Report an error